Canlyniadau Chwilio am Awdur

1

Precision medicine in pediatric oncology gan Stefan Burdach, Mike‐Andrew Westhoff, Maximilian Steinhauser, Klaus‐Michael Debatin

Cyhoeddwyd 2018

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin gan Selim Corbacioglu, Mehtap Kılıç, Mike‐Andrew Westhoff, Dirk Reinhardt, Simone Fulda, Klaus‐Michael Debatin

Cyhoeddwyd 2006

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor– and Drug-Induced Apoptosis gan Daniela Opel, Mike‐Andrew Westhoff, Ariane Bender, Veit Braun, Klaus‐Michael Debatin, Simone Fulda

Cyhoeddwyd 2008

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Src-Mediated Phosphorylation of Focal Adhesion Kinase Couples Actin and Adhesion Dynamics to Survival Signaling gan Mike‐Andrew Westhoff, Bryan Serrels, Valerie J. Fincham, Margaret C. Frame, Neil O. Carragher

Cyhoeddwyd 2004

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

A Novel Role for FAK as a Protease-Targeting Adaptor Protein gan Neil O. Carragher, Mike‐Andrew Westhoff, Valerie J. Fincham, Michael D. Schaller, Margaret C. Frame

Cyhoeddwyd 2003

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells gan Timo Burster, Rebecca Traut, Zhanerke Yermekkyzy, Katja M. Mayer, Mike‐Andrew Westhoff, Joachim Bischof, Uwe Knippschild

Cyhoeddwyd 2021

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma gan Georg Karpel‐Massler, Chiaki Tsuge Ishida, Yiru Zhang, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Markus D. Siegelin

Cyhoeddwyd 2017

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma gan Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

Cyhoeddwyd 2017

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells gan Joachim Bischof, Mike‐Andrew Westhoff, Johanna Wagner, Marc‐Eric Halatsch, Stephanie Trentmann, Uwe Knippschild, Christian Rainer Wirtz, Timo Burster

Cyhoeddwyd 2017

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma gan Mike‐Andrew Westhoff, Najmeh Faham, Daniela Marx, Lisa Nonnenmacher, Claudia Jennewein, Stefanie Enzenmüller, Patrick Gonzalez, Simone Fulda, Klaus‐Michael Debatin

Cyhoeddwyd 2013

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems gan Trang Nguyen, Yiru Zhang, Enyuan Shang, Chang Shu, Catarina M. Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

Cyhoeddwyd 2020

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

v-Src-Induced Modulation of the Calpain-Calpastatin Proteolytic System Regulates Transformation gan Neil O. Carragher, Mike‐Andrew Westhoff, Deborah Riley, David A. Potter, Previn Dutt, John S. Elce, Peter A. Greer, Margaret C. Frame

Cyhoeddwyd 2002

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo gan Georg Karpel‐Massler, Maïmouna Bâ, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

Cyhoeddwyd 2015

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo gan Georg Karpel‐Massler, Doruntina Ramani, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

Cyhoeddwyd 2016

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy gan Hannah A. Strobel, Tim Baisch, Rahel Fitzel, Katharina Schilberg, Markus D. Siegelin, Georg Karpel‐Massler, Klaus‐Michael Debatin, Mike‐Andrew Westhoff

Cyhoeddwyd 2019

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
16

RIST: A potent new combination therapy for glioblastoma gan Lisa Nonnenmacher, Mike‐Andrew Westhoff, Simone Fulda, Georg Karpel‐Massler, Marc‐Eric Halatsch, Jens Engelke, Thomas Simmet, Selim Corbacioglu, Klaus‐Michael Debatin

Cyhoeddwyd 2014

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
17

A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy gan Mike‐Andrew Westhoff, Georg Karpel‐Massler, Oliver Brühl, Stefanie Enzenmüller, Katia La Ferla-Brühl, Markus D. Siegelin, Lisa Nonnenmacher, Klaus‐Michael Debatin

Cyhoeddwyd 2014

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
18

Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo gan Georg Karpel‐Massler, Matei A. Banu, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

Cyhoeddwyd 2016

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
19

TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma gan Michaela Keuper, Ingrid Wernstedt Asterholm, Philipp E. Scherer, Mike‐Andrew Westhoff, Peter Möller, Klaus‐Michael Debatin, Gudrun Strauß, Martin Wabitsch, Pamela Fischer‐Posovszky

Cyhoeddwyd 2013

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
20

The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair gan Mike‐Andrew Westhoff, J. A. Kandenwein, Sabine Karl, Sri HariKrishna Vellanki, V. Braun, Adriana Eramo, Gregor Antoniadis, Klaus‐Michael Debatin, Simone Fulda

Cyhoeddwyd 2009

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

Precision medicine in pediatric oncology gan Stefan Burdach, Mike‐Andrew Westhoff, Maximilian Steinhauser, Klaus‐Michael Debatin

Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin gan Selim Corbacioglu, Mehtap Kılıç, Mike‐Andrew Westhoff, Dirk Reinhardt, Simone Fulda, Klaus‐Michael Debatin

Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor– and Drug-Induced Apoptosis gan Daniela Opel, Mike‐Andrew Westhoff, Ariane Bender, Veit Braun, Klaus‐Michael Debatin, Simone Fulda

Src-Mediated Phosphorylation of Focal Adhesion Kinase Couples Actin and Adhesion Dynamics to Survival Signaling gan Mike‐Andrew Westhoff, Bryan Serrels, Valerie J. Fincham, Margaret C. Frame, Neil O. Carragher

A Novel Role for FAK as a Protease-Targeting Adaptor Protein gan Neil O. Carragher, Mike‐Andrew Westhoff, Valerie J. Fincham, Michael D. Schaller, Margaret C. Frame

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells gan Timo Burster, Rebecca Traut, Zhanerke Yermekkyzy, Katja M. Mayer, Mike‐Andrew Westhoff, Joachim Bischof, Uwe Knippschild

Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma gan Georg Karpel‐Massler, Chiaki Tsuge Ishida, Yiru Zhang, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Markus D. Siegelin

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma gan Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells gan Joachim Bischof, Mike‐Andrew Westhoff, Johanna Wagner, Marc‐Eric Halatsch, Stephanie Trentmann, Uwe Knippschild, Christian Rainer Wirtz, Timo Burster

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma gan Mike‐Andrew Westhoff, Najmeh Faham, Daniela Marx, Lisa Nonnenmacher, Claudia Jennewein, Stefanie Enzenmüller, Patrick Gonzalez, Simone Fulda, Klaus‐Michael Debatin

Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems gan Trang Nguyen, Yiru Zhang, Enyuan Shang, Chang Shu, Catarina M. Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

v-Src-Induced Modulation of the Calpain-Calpastatin Proteolytic System Regulates Transformation gan Neil O. Carragher, Mike‐Andrew Westhoff, Deborah Riley, David A. Potter, Previn Dutt, John S. Elce, Peter A. Greer, Margaret C. Frame

Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i> gan Georg Karpel‐Massler, Doruntina Ramani, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy gan Hannah A. Strobel, Tim Baisch, Rahel Fitzel, Katharina Schilberg, Markus D. Siegelin, Georg Karpel‐Massler, Klaus‐Michael Debatin, Mike‐Andrew Westhoff

RIST: A potent new combination therapy for glioblastoma gan Lisa Nonnenmacher, Mike‐Andrew Westhoff, Simone Fulda, Georg Karpel‐Massler, Marc‐Eric Halatsch, Jens Engelke, Thomas Simmet, Selim Corbacioglu, Klaus‐Michael Debatin

A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy gan Mike‐Andrew Westhoff, Georg Karpel‐Massler, Oliver Brühl, Stefanie Enzenmüller, Katia La Ferla-Brühl, Markus D. Siegelin, Lisa Nonnenmacher, Klaus‐Michael Debatin

Inhibition of deubiquitinases primes glioblastoma cells to apoptosis <i>in vitro</i> and <i>in vivo</i> gan Georg Karpel‐Massler, Matei A. Banu, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair gan Mike‐Andrew Westhoff, J. A. Kandenwein, Sabine Karl, Sri HariKrishna Vellanki, V. Braun, Adriana Eramo, Gregor Antoniadis, Klaus‐Michael Debatin, Simone Fulda

Canlyniadau Chwilio - Mike‐Andrew Westhoff

Precision medicine in pediatric oncology gan Stefan Burdach, Mike‐Andrew Westhoff, Maximilian Steinhauser, Klaus‐Michael Debatin

Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin gan Selim Corbacioglu, Mehtap Kılıç, Mike‐Andrew Westhoff, Dirk Reinhardt, Simone Fulda, Klaus‐Michael Debatin

Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor– and Drug-Induced Apoptosis gan Daniela Opel, Mike‐Andrew Westhoff, Ariane Bender, Veit Braun, Klaus‐Michael Debatin, Simone Fulda

Src-Mediated Phosphorylation of Focal Adhesion Kinase Couples Actin and Adhesion Dynamics to Survival Signaling gan Mike‐Andrew Westhoff, Bryan Serrels, Valerie J. Fincham, Margaret C. Frame, Neil O. Carragher

A Novel Role for FAK as a Protease-Targeting Adaptor Protein gan Neil O. Carragher, Mike‐Andrew Westhoff, Valerie J. Fincham, Michael D. Schaller, Margaret C. Frame

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells gan Timo Burster, Rebecca Traut, Zhanerke Yermekkyzy, Katja M. Mayer, Mike‐Andrew Westhoff, Joachim Bischof, Uwe Knippschild

Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma gan Georg Karpel‐Massler, Chiaki Tsuge Ishida, Yiru Zhang, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Markus D. Siegelin

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma gan Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells gan Joachim Bischof, Mike‐Andrew Westhoff, Johanna Wagner, Marc‐Eric Halatsch, Stephanie Trentmann, Uwe Knippschild, Christian Rainer Wirtz, Timo Burster

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma gan Mike‐Andrew Westhoff, Najmeh Faham, Daniela Marx, Lisa Nonnenmacher, Claudia Jennewein, Stefanie Enzenmüller, Patrick Gonzalez, Simone Fulda, Klaus‐Michael Debatin

Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems gan Trang Nguyen, Yiru Zhang, Enyuan Shang, Chang Shu, Catarina M. Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

v-Src-Induced Modulation of the Calpain-Calpastatin Proteolytic System Regulates Transformation gan Neil O. Carragher, Mike‐Andrew Westhoff, Deborah Riley, David A. Potter, Previn Dutt, John S. Elce, Peter A. Greer, Margaret C. Frame

Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i> gan Georg Karpel‐Massler, Doruntina Ramani, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy gan Hannah A. Strobel, Tim Baisch, Rahel Fitzel, Katharina Schilberg, Markus D. Siegelin, Georg Karpel‐Massler, Klaus‐Michael Debatin, Mike‐Andrew Westhoff

RIST: A potent new combination therapy for glioblastoma gan Lisa Nonnenmacher, Mike‐Andrew Westhoff, Simone Fulda, Georg Karpel‐Massler, Marc‐Eric Halatsch, Jens Engelke, Thomas Simmet, Selim Corbacioglu, Klaus‐Michael Debatin

A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy gan Mike‐Andrew Westhoff, Georg Karpel‐Massler, Oliver Brühl, Stefanie Enzenmüller, Katia La Ferla-Brühl, Markus D. Siegelin, Lisa Nonnenmacher, Klaus‐Michael Debatin

Inhibition of deubiquitinases primes glioblastoma cells to apoptosis <i>in vitro</i> and <i>in vivo</i> gan Georg Karpel‐Massler, Matei A. Banu, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair gan Mike‐Andrew Westhoff, J. A. Kandenwein, Sabine Karl, Sri HariKrishna Vellanki, V. Braun, Adriana Eramo, Gregor Antoniadis, Klaus‐Michael Debatin, Simone Fulda

Offerynnau Chwilio:

Pynciau Perthynol